Cargando…

An Extremely Rapid Case of Pneumonitis with the Use of Nivolumab for Pancreatic Adenocarcinoma

Pancreatic cancer is the fourth most common cancer death in the United States despite comprising a small percentage of the total number of cancer cases. The estimated 5-year overall survival (OS) for patients with distant metastatic disease is approximately 3%. New treatment options are an unmet nee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Rubens Barros, Benson, Al, Yaghmai, Vahid, Costa, Ricardo L. B., Zhou, Haijun, Behdad, Amir, Kaplan, Jason B., Sadim, Maureen, Talamantes, Sarah, Kalyan, Aparna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902098/ https://www.ncbi.nlm.nih.gov/pubmed/29808141 http://dx.doi.org/10.1155/2018/6314392

Ejemplares similares

Interstitial Pneumonitis Secondary to Trastuzumab: A Case Report and Literature Review
por: Costa, Ricardo, et al.
Publicado: (2017)

Nivolumab: Interstitial pneumonitis: case report
Publicado: (2020)

Extracorporeal Membrane Oxygenation in Nivolumab Associated Pneumonitis
por: Schneider, Thomas-Michael, et al.
Publicado: (2017)

Ipilimumab/nivolumab: Diffuse pneumonitis: case report
Publicado: (2020)

Nivolumab-Induced Pneumonitis in a Patient With Urothelial Cancer
por: Kasi, Arbab Furquan Ud din, et al.
Publicado: (2023)

Severe Pneumonitis after Nivolumab Treatment Accompanied by Acute Pulmonary Embolism in a Patient with Lung Adenocarcinoma
por: Liao, Ji-Ping, et al.
Publicado: (2017)

Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis
por: Vansteenkiste, Johan
Publicado: (2017)

Ipilimumab/nivolumab: Immune-related pneumonitis: 2 case reports
Publicado: (2020)

Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancer
por: Costa, Rubens Barros, et al.
Publicado: (2018)

MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma
por: Eresen, Aydin, et al.
Publicado: (2020)

Radiation recall pneumonitis induced by nivolumab in a patient with renal cell carcinoma
por: Nakamura, Kenji, et al.
Publicado: (2018)

Concomitant Human Herpes Virus 6 and nivolumab-related pneumonitis: Potential pathogenetic insights
por: Foukas, Periklis G., et al.
Publicado: (2018)

Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events
por: Imafuku, Keisuke, et al.
Publicado: (2017)

A Case of Immune-Mediated Pneumonitis Associated With Dual Nivolumab and Ipilimumab Immunotherapy Treatment
por: Al-Saghir, Tala, et al.
Publicado: (2023)

High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review
por: Koyama, N., et al.
Publicado: (2018)

Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
por: Souza, Ive L., et al.
Publicado: (2020)

Successful osimertinib retreatment after extremely early onset severe pneumonitis in first‐line treatment of lung adenocarcinoma
por: Ahn, June Hong
Publicado: (2020)

Psoriasiform eruption on the face and extremities associated with nivolumab therapy
por: Om, Amit, et al.
Publicado: (2018)

Analyses of selected safety endpoints in phase 1 and late-phase clinical trials of anti-PD-1 and PD-L1 inhibitors: prediction of immune-related toxicities
por: Costa, Ricardo, et al.
Publicado: (2017)

Advanced Lung Adenocarcinoma with Nivolumab-associated Dermatomyositis
por: Kudo, Fumiaki, et al.
Publicado: (2018)

Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab
por: Kawashima, Yosuke, et al.
Publicado: (2019)

Case Report: Pseudoprogression With Nivolumab and Bevacizumab Followed by Recurrent Immune-Related Pneumonitis in Urothelial Carcinoma With Lung Metastasis
por: Yang, Zizhong, et al.
Publicado: (2021)

Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy
por: Noda‐Narita, Shoko, et al.
Publicado: (2022)

Preoperative assessment of lymph node metastasis in Colon Cancer patients using machine learning: a pilot study
por: Eresen, Aydin, et al.
Publicado: (2020)

A Rare Case of Glioblastoma Multiforme with Osseous Metastases
por: Costa, Rubens Barros, et al.
Publicado: (2017)

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
por: Zhou, Shi, et al.
Publicado: (2019)

Broncho-Pneumonitis
por: Anderson, R. B.
Publicado: (1877)

Strategies to improve sorafenib efficacy during image-guided treatment of hepatocellular carcinoma
por: Eresen, Aydin, et al.
Publicado: (2021)

Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma
por: Yoo, Sang Hoon, et al.
Publicado: (2016)

Pneumonic‐type mucinous lung adenocarcinoma diagnosed by transbronchial cryobiopsy
por: Balestra, Rick, et al.
Publicado: (2017)

Comparative study of imaging and pathological evaluation of pneumonic mucinous adenocarcinoma
por: Han, Jun, et al.
Publicado: (2021)

Wolf in sheep’s clothes: An uncommon case of pneumonic-type adenocarcinoma
por: Maasdorp, S D
Publicado: (2021)

Improvement in recurring nivolumab-induced pneumonitis with repetitive administration of infliximab in a patient with head and neck cancer: A case report
por: Ueno, Shohei, et al.
Publicado: (2021)

Pre-existing interstitial lung disease is associated with onset of nivolumab-induced pneumonitis in patients with solid tumors: a retrospective analysis
por: Yamaguchi, Teppei, et al.
Publicado: (2021)

MRI Assessment of Associations between Brown Adipose Tissue and Cachexia in Murine Pancreatic Ductal Adenocarcinoma
por: Zhang, Yaqi, et al.
Publicado: (2019)

An extremely rare case of nivolumab‐associated macroscopic duodenitis with spontaneous regression
por: Akizawa, Takatora, et al.
Publicado: (2020)

Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine
por: Ferreira, Pedro Gonçalo, et al.
Publicado: (2014)

The Significant Antitumor Activity of Nivolumab in Lung Adenocarcinoma with Choriocarcinomatous Features
por: Ochi, Mieko, et al.
Publicado: (2018)

Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma
por: Shah, Suma, et al.
Publicado: (2018)

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
por: Birnbaum, Mathew R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i9m5k2u1v9hadvhb98fj0ublik